Endocyte (ECYT) Stock Research, Analysis & News

Quick Analysis on Endocyte (ECYT) Stock as of August 20, 2017

Previous Closing Price $1.28 is below its 50 day moving average $1.42
Previous Closing Price $1.28 is below its 200 day moving average $2.01
The Stock pays no dividend
The closing price $1.28 is more than 56.25% away from its one year target price of $2.00
Good Price to Book Ratio of 0.47
Current Short Ratio 2.55 is great than 1
Earning per Share $-1.01 is negative. Endocyte is lossing money.
EBITDA $-40.60M is negative
(See more information about Endocyte (ECYT) Stock below)

Endocyte (ECYT) Stock Profile Summary

Endocyte, Inc., a biopharmaceutical company, engages in developing targeted therapies for the treatment of cancer and inflammatory diseases. The company uses its proprietary technology to create novel small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized targeted therapies. Its SMDCs target receptors that are over-expressed on diseased cells, relative to healthy cells. This targeted approach is designed to enable the treatment of patients with highly active drugs at greater doses, delivered more frequently, and over longer periods of time than would be possible with the untargeted drug alone. The companys principal SMDC product, EC145, has been evaluated in a randomized phase 2 clinical trial for the treatment of women with platinum-resistant ovarian cancer, and it also completed a phase 2 single-arm clinical trial for advanced non-small cell lung cancer. Its companion imaging diagnostics are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. Endocyte, Inc. was founded in 1995 and is based in West Lafayette, Indiana.

Endocyte (ECYT) Stock Key Statistics Research and Analysis as of August 20, 2017

Stock ExchangeNMS
Market Capitalization$51.52M
Trade Volume (Average Trading Volume)1,416,773 (587,820)
Price/Sales778.51
Price/Book0.47
Earning/Share$-1.01
Current Year EPS Estimate$-0.93
Next Year EPS Estimate$-0.81
Previous Closing Price$1.28
50 Day Price Moving Average$1.42
200 Day Price Moving Average$2.01
1 yr Target Price$2.00
PEG Ratio0.00
Short Ratio2.55
EBITDA$-40.60M

Stock Research on Endocyte (ECYT)

Latest Market News on Endocyte (ECYT)


Click here to find the latest news on Endocyte (ECYT)

Looking for Market Opportunties?


Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center